Cargando…

Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy

PURPOSE: For precision medicine, exploration and monitoring of molecular biomarkers are essential. However, in advanced gastric cancer (GC) with visceral lesions, an invasive procedure cannot be performed repeatedly for the follow-up of molecular biomarkers. MATERIALS AND METHODS: To verify the clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Seung-Hyun, Lee, Choong-kun, Kwon, Woo Sun, Yun, Sujin, Jung, Minkyu, Kim, Hyo Song, Chung, Hyun Cheol, Chung, Yeun-Jun, Rha, Sun Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462813/ https://www.ncbi.nlm.nih.gov/pubmed/37634629 http://dx.doi.org/10.3349/ymj.2023.0096

Ejemplares similares

Breakthroughs in the Systemic Treatment of HER2-Positive Advanced/Metastatic Gastric Cancer: From Singlet Chemotherapy to Triple Combination
por: Rha, Sun Young, et al.
Publicado: (2023)

A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer
por: Lee, Choong-kun, et al.
Publicado: (2022)

Probe-Based Confocal Laser Endomicroscopy versus White-Light Endoscopy with Narrow-Band Imaging for Predicting and Collecting Residual Cancer Tissue in Patients with Gastric Cancer Receiving Chemotherapy
por: Kim, Yuna, et al.
Publicado: (2022)

Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
por: Soo Park, Ji, et al.
Publicado: (2017)

Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer
por: Park, Hyung Soon, et al.
Publicado: (2019)

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
por: Lee, Choong-kun, et al.
Publicado: (2015)

Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy
por: Jung, Minkyu, et al.
Publicado: (2012)

PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
por: Kim, Chan, et al.
Publicado: (2017)

Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab
por: Lee, Choong-Kun, et al.
Publicado: (2017)

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
por: Lee, Choong-kun, et al.
Publicado: (2019)

Detection of asymptomatic recurrence improves survival of gastric cancer patients
por: Park, Ji Soo, et al.
Publicado: (2021)

Classification of subtypes including LCNEC in lung cancer biopsy slides using convolutional neural network from scratch
por: Yang, Jung Wook, et al.
Publicado: (2022)

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019)

Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status
por: Ha, Seon-Ah, et al.
Publicado: (2009)

Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
por: Beom, Seung-Hoon, et al.
Publicado: (2018)

Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer
por: Bortolini Silveira, Amanda, et al.
Publicado: (2021)

Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
por: Shen, Lin
Publicado: (2018)

Liquid biopsy in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience
por: Jung, Minkyu, et al.
Publicado: (2012)

The Predictive Value of Serum HER2/neu for Response to Anthracycline-Based and Trastuzumab-Based Neoadjuvant Chemotherapy
por: Lee, Jung Sun, et al.
Publicado: (2012)

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
por: Lee, Ji Hyun, et al.
Publicado: (2013)

Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy
por: Fatima, Shadma, et al.
Publicado: (2022)

New Variants Including ARG1 Polymorphisms Associated with C-Reactive Protein Levels Identified by Genome-Wide Association and Pathway Analysis
por: Vinayagamoorthy, Nadimuthu, et al.
Publicado: (2014)

The Metastatic Cascade as the Basis for Liquid Biopsy Development
por: Eslami-S, Zahra, et al.
Publicado: (2020)

Evaluation of Liquid Biopsy in Patients with HER2-Positive Breast Cancer
por: Huai, Jianguo, et al.
Publicado: (2021)

Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib
por: Shishido, Stephanie N., et al.
Publicado: (2022)

Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
por: Klein-Scory, Susanne, et al.
Publicado: (2020)

Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
por: Chon, Hong Jae, et al.
Publicado: (2011)

Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations
por: Lee, Jii Bum, et al.
Publicado: (2021)

Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer
por: Wan, Guoxing, et al.
Publicado: (2019)

Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer
por: Lee, Jieun, et al.
Publicado: (2017)

Unveiling the Potential of Liquid Biopsy in HER2-Positive Breast Cancer Management
por: Godoy-Ortiz, Ana, et al.
Publicado: (2022)

Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer
por: Gao, Wei, et al.
Publicado: (2021)

Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea
por: Lee, Si Won, et al.
Publicado: (2023)

Liquid–liquid phase separation drives herpesvirus assembly in the cytoplasm
por: Chung, Woo-Chang, et al.
Publicado: (2022)

Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy
por: Lee, Jeongshim, et al.
Publicado: (2020)

Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function
por: Kim, Hye Ryun, et al.
Publicado: (2019)

Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators
por: Byun, Hwa Kyung, et al.
Publicado: (2021)

A Case of Biopsy-proven Early-onset Alzheimer's Disease with Hemiparkinsonism
por: Choi, Eun Jung, et al.
Publicado: (2005)

Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
por: Kim, Min Hwan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ddmlj1vp3hj51v8on10ogsq785